Selectis Health, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 0.156869 million compared to USD 0.387903 million a year ago. Revenue was USD 11.47 million compared to USD 6.01 million a year ago. Net income was USD 1.03 million compared to net loss of USD 0.67878 million a year ago. Basic earnings per share from continuing operations was USD 0.34 compared to basic loss per share from continuing operations of USD 0.26 a year ago. Diluted earnings per share from continuing operations was USD 0.34 compared to diluted loss per share from continuing operations of USD 0.26 a year ago.
For the six months, sales was USD 0.311063 million compared to USD 0.778289 million a year ago. Revenue was USD 21.56 million compared to USD 11.77 million a year ago. Net income was USD 1.26 million compared to net loss of USD 0.430724 million a year ago. Basic earnings per share from continuing operations was USD 0.41 compared to basic loss per share from continuing operations of USD 0.17 a year ago. Diluted earnings per share from continuing operations was USD 0.41 compared to diluted loss per share from continuing operations of USD 0.17 a year ago.